Manufacturer or GPO Program year 2025 Source: CMS Open Payments

Grifols Biologicals LLC

CA, United States

CMS manufacturer 100000005423

Open in the dashboard

General payments

$113,108

120 payments

Research payments

$5,029,087

913 payments

Ownership & investment interest

$0

None reported

Through program year 2025, Grifols Biologicals LLC reported paying $113,108 in general payments and $5,029,087 in research payments to U.S. physicians, teaching hospitals and other recipients.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

8 rows
Year Kind Amount Payments
2025 Research $598,575 31
2024 Research $34,045 12
2023 Research $237,548 43
2022 Research $748,104 216
2021 Research $709,697 233
2020 Research $557,879 201
2019 General $113,108 120
2019 Research $2,143,238 177

Breakdown

Top recipients General payments · program year 2019
  1. Oscar Lopez Pittsburgh, PA $38,893 26 payments
  2. Jeffrey Cummings Neurology · Los Angeles, CA $16,315 9 payments
  3. Zbigniew Szczepiorkowski Blood Banking & Transfusion Medicine · Lebanon, NH $11,907 10 payments
  4. Meelie Debroy Surgery · Valhalla, NY $8,788 5 payments
  5. Jasmohan Bajaj Gastroenterology · Richmond, VA $5,724 5 payments
  6. Tarek Hassanein Hepatology · Coronado, CA $5,573 5 payments
  7. Nilang Patel Nephrology · Richmond, VA $5,408 5 payments
  8. Ethan Weinberg Gastroenterology · Philadelphia, PA $3,520 5 payments
  9. Ram Subramanian Hepatology · Atlanta, GA $3,253 5 payments
  10. John Videen Nephrology · Chula Vista, CA $2,490 5 payments
Top research recipients Research payments · program year 2025
  1. Gabrail Cancer Center Research LLC $336,865 6 payments
  2. Walter Reed National Military Medical Center $261,710 25 payments
Products the payments named General payments · program year 2019
  1. Albutein Critical Care Medicine $107,439 59% · 22 recipients
  2. Flebogamma DIF Immnunology $76,202 41% · 14 recipients

Each share is of this company’s general payments naming a product in 2019. A payment can name up to five products, so these amounts overlap.

Specialties paid General payments · program year 2019
  1. Neurology Psychiatry & Neurology $16,771 23% · 2 practitioners
  2. Blood Banking & Transfusion Medicine Pathology $11,907 16% · 1 practitioner
  3. Gastroenterology Internal Medicine $9,244 13% · 2 practitioners
  4. Hepatology Internal Medicine $8,826 12% · 2 practitioners
  5. Surgery $8,788 12% · 1 practitioner

The top 5 of 12 specialties; each share is of this company’s general payments to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. Pennsylvania $42,508 38% · 3 recipients
  2. Nevada $16,315 14% · 1 recipient
  3. Massachusetts $14,718 13% · 3 recipients
  4. Texas $8,788 8% · 1 recipient
  5. California $8,063 7% · 2 recipients

The top 5 of 13 states; each share is of this company’s general payments in 2019 where a state was reported.

The top 25 states, free in the app

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $96,529 94 payments
  2. Consulting Fee $13,650 6 payments
  3. Food and Beverage $1,467 19 payments
  4. Honoraria $1,462 1 payment
Companies with a similar name General payments · program years 2019–2025
  1. Grifols USA, LLC CA, United States $9,592,710
  2. Grifols, S.A. Spain $3,916,130
  3. Grifols Shared Services North America, Inc. CA, United States $1,361,493
  4. Grifols Diagnostic Solutions, Inc. CA, United States $142,827
  5. Grifols Therapeutics LLC CA, United States $27,907
  6. Grifols Canada Ltd. Canada $14,900

Grouped by name only. CMS publishes no corporate ownership, so a shared name does not mean a shared parent.

120 general · 913 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers of drugs, devices and biologicals, and group purchasing organisations, are required to report the payments and transfers of value they make to physicians and teaching hospitals. This page shows what this company reported.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record